These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23715190)

  • 1. [Differential expression of proteins in Leishmania (Viannia) panamensis associated with mechanisms of resistance to meglumine antimoniate].
    Peláez RG; Muskus CE; Cuervo P; Marín-Villa M
    Biomedica; 2012 Sep; 32(3):418-29. PubMed ID: 23715190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of Leishmania viannia panamensis to pentavalent antimony is correlated with the formation of cleavable DNA-protein complexes.
    Lucumi A; Robledo S; Gama V; Saravia NG
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1990-5. PubMed ID: 9687395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.
    Barrera MC; Rojas LJ; Weiss A; Fernandez O; McMahon-Pratt D; Saravia NG; Gomez MA
    Acta Trop; 2017 Dec; 176():355-363. PubMed ID: 28843396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug.
    Varela M RE; Muñoz DL; Robledo SM; Kolli BK; Dutta S; Chang KP; Muskus C
    Exp Parasitol; 2009 Jun; 122(2):134-9. PubMed ID: 19303871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis.
    Fernández OL; Rosales-Chilama M; Sánchez-Hidalgo A; Gómez P; Rebellón-Sánchez DE; Regli IB; Díaz-Varela M; Tacchini-Cottier F; Saravia NG
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012156. PubMed ID: 38709850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility.
    Moreira ES; Anacleto C; Petrillo-Peixoto ML
    Parasitol Res; 1998 Sep; 84(9):720-6. PubMed ID: 9766900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
    Fernández OL; Diaz-Toro Y; Ovalle C; Valderrama L; Muvdi S; Rodríguez I; Gomez MA; Saravia NG
    PLoS Negl Trop Dis; 2014 May; 8(5):e2871. PubMed ID: 24853871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyjanensis cell lines.
    Gazola KC; Ferreira AV; Anacleto C; Michalick MS; Andrade AF; Moreira ES
    Parasitol Res; 2001 Nov; 87(11):935-40. PubMed ID: 11728019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomics study on meglumine antimoniate sensitive and resistant Leishmania tropica isolated from Iranian anthroponotic cutaneous leishmaniasis patients.
    Hajjaran H; Azarian B; Mohebali M; Hadighi R; Assareh A; Vaziri B
    East Mediterr Health J; 2012 Feb; 18(2):165-71. PubMed ID: 22571094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression analysis of activated protein kinase C gene (LACK1) in antimony sensitive and resistant Leishmania tropica clinical isolates using real-time RT-PCR.
    Hajjaran H; Kazemi-Rad E; Mohebali M; Oshaghi MA; Khadem-Erfan MB; Hajaliloo E; Reisi Nafchi H; Raoofian R
    Int J Dermatol; 2016 Sep; 55(9):1020-6. PubMed ID: 27336481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis.
    Walker J; Gongora R; Vasquez JJ; Drummelsmith J; Burchmore R; Roy G; Ouellette M; Gomez MA; Saravia NG
    Mol Biochem Parasitol; 2012 Jun; 183(2):166-76. PubMed ID: 22449941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
    Delgado G; Puentes F; Moreno A; Patarroyo ME
    Pharmacol Res; 2001 Oct; 44(4):281-6. PubMed ID: 11592861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania (V.) guyanensis: isolation and characterization of glucantime-resistant cell lines.
    Ferreira-Pinto KC; Miranda-Vilela AL; Anacleto C; Fernandes AP; Abdo MC; Petrillo-Peixoto ML; Moreira ES
    Can J Microbiol; 1996 Sep; 42(9):944-9. PubMed ID: 8864217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
    Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
    Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of
    Regli IB; Fernández OL; Martínez-Salazar B; Gómez MA; Saravia NG; Tacchini-Cottier F
    Front Immunol; 2018; 9():3040. PubMed ID: 30622537
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line.
    Anacleto C; Abdo MC; Ferreira AV; Murta SM; Romanha AJ; Fernandes AP; Moreira ES
    Parasitol Res; 2003 Jun; 90(2):110-8. PubMed ID: 12756544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.
    Torres DC; Ribeiro-Alves M; Romero GA; Dávila AM; Cupolillo E
    Acta Trop; 2013 May; 126(2):132-41. PubMed ID: 23416123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani.
    Kumar A; Sisodia B; Misra P; Sundar S; Shasany AK; Dube A
    Br J Clin Pharmacol; 2010 Oct; 70(4):609-17. PubMed ID: 20840452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
    Dzamitika SA; Falcão CA; de Oliveira FB; Marbeuf C; Garnier-Suillerot A; Demicheli C; Rossi-Bergmann B; Frézard F
    Chem Biol Interact; 2006 Apr; 160(3):217-24. PubMed ID: 16524568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to antimony and treatment failure in human Leishmania (Viannia) infection.
    Rojas R; Valderrama L; Valderrama M; Varona MX; Ouellette M; Saravia NG
    J Infect Dis; 2006 May; 193(10):1375-83. PubMed ID: 16619185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.